MedTrace Logo

Population PK of Antibiotics, Sedative and Analgesics, and Antiplatelet Drugs During ECMO

NCT05406492 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2022-06-27

No results posted yet for this study

Summary

The purpose of this study is to optimize the dosage regimen of drugs in patients during during Extracorporeal Membrane Oxygenation (ECMO) by population pharmacokinetic modeling.

Conditions

  • Pharmacokinetics
  • Extracorporeal Membrane Oxygenation

Interventions

OTHER

Residual blood

Residual blood samples(1\~2 cc) at each sampling time are collected from all subjects while using ECMO for drug concentration assays(LC-MS/MS etc.).

Sponsors & Collaborators

  • Yonsei University

    collaborator OTHER

  • Gachon University Gil Medical Center

    lead OTHER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-16
Primary Completion
2024-07-15
Completion
2024-07-15

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05406492 on ClinicalTrials.gov